- Drugs
- Wednesday, 18 Dec 2019
Medical Marijuana, Inc. Appoints New Chief Financial Officer
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has promoted its VP of Corporate Finance Brooke Beers to Chief Financial Officer of the Company.
"Brooke's contributions to the Company have been extraordinary," said Medical Marijuana, Inc. COO Blake Schroeder. "He's helped us overcome several financial obstacles that many cannabis companies face every day and he has helped us significantly improve our public reporting practices to increase transparency."
Beers was hired by Medical Marijuana, Inc. in 2017 and has since been leading the Company's accounting department, handling the Company's budget management, public financial reports, e-commerce offerings, and forecasting needs.
"Working with the Medical Marijuana, Inc. team has been an incredibly rewarding experience," said Beers. "Last December, the Brightfield Group reported that our Company represents 10 percent of the entire CBD market and I'm proud to be a part of that financial milestone and many more to come. It's encouraging to work with a large group of highly motivated professionals and claim our stake in the global CBD industry."
Related Industry Updates
CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset
Dec 02, 2019
Prostate Cancer Therapeutics Market is expected to grow US$ 28,425.27 million by 2030
Dec 12, 2023
Investors Hunting for Winners in Ashes of Industry Fire up Rally in Cannabis Stocks
Jan 24, 2020
Geneyork Pharmaceutical Announces U.S. Launch of Generic Version of Deltasone® (Prednisone) Tablets
Feb 03, 2020
Cold, Cough and Sore Throat Remedies Market Report Offers Intelligence And Forecast Till 2027
Nov 26, 2020
Malaria and Sickle Cell Disease Treatment Market is expected to reach US$ 29,179.60 million by 2030
Nov 03, 2023
Nasal Polyps Treatment Market Size will Escalate Rapidly in the Near Future 2020: Forecast 2027 by OptiNose US, Inc. , Regeneron Pharmaceuticals, Inc. , Merck KGaA , Pfizer, Inc.
Apr 09, 2021